Atlas Trials

A Study to Assess the Efficacy and Safety of the Triptorelin 6-month Formulation in Paediatric Participants With Central Precocious Puberty.

Clinical trial NCT05029622 · COMPLETED

Trial details

NCT number
NCT05029622
Sponsor
Ipsen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Central Precocious Puberty
Start date
2021-08-10
Primary completion
2022-08-21
Enrollment
66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.